Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up

Journal of Psychiatric Research

Volumn 65, Issue , 2015, Pages 115-123

  Brandizzi, M ^a,b   Valmaggia, L ^a,c   Byrne, M ^a   Jones, C ^a   Iwegbu, N ^c   Badger, S ^c   McGuire, P ^a,c   Fusar Poli, P ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Functioning; Outcome; Prodromal; Psychosis; Remission; Schizophrenia; Ultra high risk

Indexed keywords

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; AUTOMUTILATION; COMORBIDITY; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GLOBAL ASSESSMENT OF FUNCTIONING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTCOME VARIABLE; PRIORITY JOURNAL; PSYCHOSIS; SEX DIFFERENCE; ANALYSIS OF VARIANCE; DISEASE COURSE; EMPLOYMENT; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRODROMAL SYMPTOM; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOTIC DISORDERS; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; DISEASE PROGRESSION; EMPLOYMENT; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRODROMAL SYMPTOMS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84929508085     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.03.005     Document Type: Article

References (68)

1. Addington J., Cornblatt B.A., Cadenhead K.S., Cannon T.D., Mcglashan T.H., Perkins D.O., et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 2011, 168:800-805.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, Washington, DC. 4th ed.
3. APA Diagnostic and statistical manual of mental disorders: Dsm-5 2013, Amer Psychiatric Pub Incorporated.
4. Auther A.M., Mclaughlin D., Carrion R.E., Nagachandran P., Correll C.U., Cornblatt B.A. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med 2012, 42:2485-2497.
5. Bachmann S., Bottmer C., Schroder J. One-year outcome and its prediction in first-episode schizophrenia - a naturalistic study. Psychopathology 2008, 41:115-123.
6. Ballon J.S., Kaur T., Marks I.I., Cadenhead K.S. Social functioning in young people at risk for schizophrenia. Psychiatry Res 2007, 151:29-35.
7. Barajas A., Usall J., Banos I., Dolz M., Villalta-Gil V., Vilaplana M., et al. Three-factor model of premorbid adjustment in a sample with chronic schizophrenia and first-episode psychosis. Schizophr Res 2013, 151:252-258.
8. Bearden C.E., Wu K.N., Caplan R., Cannon T.D. Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis. JAm Acad Child Adolesc Psychiatry 2011, 50:669-680.
9. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., et al. Prediction of psychosis in youth at high clinical risk. Arch General Psychiatry 2008, 65:28-37.
10. Carrion R.E., Mclaughlin D., Goldberg T.E., Auther A.M., Olsen R.H., Olvet D.M., et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry 2013, 70:1133-1142.
11. Chang W.C., Tang J.Y., Hui C.L., Wong G.H., Chan S.K., Lee E.H., et al. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Psychiatry Res 2013, 209:353-360.
12. Clement S., Schauman O., Graham T., Maggioni F., Evans-Lacko S., Bezborodovs N., et al. What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychol Med 2014, 1-17.
13. Cornblatt B.A. The New York high risk project to the Hillside recognition and prevention (RAP) program. Am J Med Genet 2002, 114:956-966.
14. Cornblatt B.A., Auther A.M., Niendam T., Smith C.W., Zinberg J., Bearden C.E., et al. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull 2007, 33:688-702.
15. Cornblatt B.A., Carrion R.E., Addington J., Seidman L., Walker E.F., Cannon T.D., et al. Risk factors for psychosis: impaired social and role functioning. Schizophr Bull 2012, 38:1247-1257.
16. Cornblatt B.A., Lencz T., Smith C.W., Correll C.U., Auther A.M., Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull 2003, 29:633-651.
17. Cox D.R., Snell E.J. Analysis of binary data 1989, Taylor & Francis. 2nd ed.
18. De Wit S., Schothorst P.F., Oranje B., Ziermans T.B., Durston S., Kahn R.S. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state. Eur Neuropsychopharmacol 2014, 24:865-873.
19. Demjaha A., Valmaggia L., Stahl D., Byrne M., Mcguire P. Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull 2012, 38:351-359.
20. Di Forti M., Morgan C., Dazzan P., Pariante C., Mondelli V., Marques T.R., et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry 2009, 195:488-491.
21. Eslami A., Jahshan C., Cadenhead K.S. Disorganized symptoms and executive functioning predict impaired social functioning in subjects at risk for psychosis. JNeuropsychiatry Clin Neurosci 2011, 23:457-460.
22. ® axis II personality disorders (SCID-II) 1997, American Psychiatric Press.
23. ® axis I disorders (SCID-I), clinician version, administration booklet 2012, American Psychiatric Publishing.
24. Fowler D., Hodgekins J., Painter M., Reilly T., Crane C., Macmillan I., et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC trial platform study (improving social recovery in early psychosis). Psychol Med 2009, 39:1627-1636.
25. Fusar-Poli P., Bechdolf A., Taylor M.J., Bonoldi I., Carpenter W.T., Yung A.R., et al. At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull 2013, 39:923-932.
26. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M., Barale F., et al. Predicting psychosis: a meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012, 69:1-10.
27. Fusar-Poli P., Borgwardt S., Bechdolf A., Addington J., Riecher-Rossler A., Schultze-Lutter F., et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013, 70:107-120.
28. Fusar-Poli P., Broome M.R., Matthiasson P., Woolley J., Mechelli A., Johns L., et al. Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis. Schizophr Bull 2011, 37:189-198.
29. Fusar-Poli P., Byrne M., Badger S., Valmaggia L.R., Mcguire P.K. Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur Psychiatry 2013, 28:315-326.
30. Fusar-Poli P., Byrne M., Valmaggia L., Day F., Tabraham P., Johns L., et al. Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. JPsychiatr Res 2010, 44:294-301.
31. Fusar-Poli P., Frascarelli M., Valmaggia L., Byrne M., Stahl D., Rocchetti M., et al. Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study. Psychol Med 2014, 1-13.
32. Fusar-Poli P., Meneghelli A., Valmaggia L., Allen P., Galvan F., Mcguire P., et al. Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. Br J Psychiatry 2009, 194:181-182.
33. Fusar-Poli P., Nelson B., Valmaggia L., Yung A.R., McGuire P.K. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 2014, 40(1):120-131.
34. Fusar-Poli P., Rocchetti M., Sardella A., Avila A., Brandizzi M., Caverzasi E., et al. Disorder, not just state of risk: meta-analysis of functioning and quality of life in subjects at high clinical risk for psychosis. Br J Psychiatry 2015, BJP/2014/157115.
35. Fusar-Poli P., Van Os J. Lost in transition: setting psychosis threshold in prodromal research. Acta Psychiatr Scand 2013 Mar, 127(3):248-252.
36. Fusar-Poli P., Yung A.R., Mcgorry P., Van Os J. Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med 2014, 44:17-24.
37. Hall R.C. Global assessment of functioning. A modified scale. Psychosomatics 1995, 36:267-275.
38. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55.
39. Hamilton M. Arating scale for depression. JNeurol Neurosurg Psychiatry 1960, 23:56-62.
40. Harris M.G., Henry L.P., Harrigan S.M., Purcell R., Schwartz O.S., Farrelly S.E., et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 2005, 79:85-93.
41. Harrison G., Hopper K., Craig T., Laska E., Siegel C., Wanderling J., et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001, 178:506-517.
42. Hegelstad W.T., Larsen T.K., Auestad B., Evensen J., Haahr U., Joa I., et al. Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. Am J Psychiatry 2012, 169:374-380.
43. Huber G., Gross G. The concept of basic symptoms in schizophrenic and schizoaffective psychoses. Recenti Prog Med 1989, 80:646-652.
44. Jalbrzikowski M., Krasileva K.E., Marvin S., Zinberg J., Andaya A., Bachman P., et al. Reciprocal social behavior in youths with psychotic illness and those at clinical high risk. Dev Psychopathol 2013, 25:1187-1197.
45. Kim K.R., Song Y.Y., Park J.Y., Lee E.H., Lee M., Lee S.Y., et al. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry 2013, 47:762-771.
46. Kirkbride J.B., Fearon P., Morgan C., Dazzan P., Morgan K., Tarrant J., et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry 2006, 63:250-258.
47. Lin A., wood S.J., Nelson B., Brewer W.J., Spiliotacopoulos D., Bruxner A., et al. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophr Res 2011, 132:1-7.
48. Masillo A., Day F., Laing J., Howes O., Fusar-Poli P., Byrne M., et al. Interpersonal sensitivity in the at-risk mental state for psychosis. Psychol Med 2012, 42:1835-1845.
49. Niendam T.A., Bearden C.E., Zinberg J., Johnson J.K., O'brien M., Cannon T.D. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr Bull 2007, 33:772-781.
50. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005, 162:1785-1804.
51. Ruhrmann S., Schultze-Lutter F., Salokangas R.K., Heinimaa M., Linszen D., Dingemans P., et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010, 67:241-251.
52. Sabb F.W., Van Erp T.G., Hardt M.E., Dapretto M., Caplan R., Cannon T.D., et al. Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis. Schizophr Res 2010, 116:173-183.
53. Salokangas R.K., Heinimaa M., From T., Loyttyniemi E., Ilonen T., Luutonen S., et al. Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project. Eur Psychiatry 2014, 29:371-380.
54. Schennach-Wolff R., Jager M., Seemuller F., Obermeier M., Messer T., Laux G., et al. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res 2009, 113:210-217.
55. Schlosser D.A., Jacobson S., Chen Q., Sugar C.A., Niendam T.A., Li G., et al. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull 2012, 38:1225-1233.
56. Schultze-Lutter F., Klosterkotter J., Ruhrmann S. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res 2014, 154:100-106.
57. Schultze-Lutter F., Michel C., Ruhrmann S., Schimmelmann B.G. Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern epidemiological at-risk (BEAR) study. Schizophr Bull 2014, 40(6):1499-1508. 10.1093/schbul/sbt171.
58. Stafford M.R., Jackson H., Mayo-Wilson E., Morrison A.P., Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ 2013, 346:f185.
59. Tarbox S.I., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Perkins D.O., et al. Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev Psychopathol 2013, 25:1171-1186.
60. Tosato S., Lasalvia A., Bonetto C., Mazzoncini R., Cristofalo D., De Santi K., et al. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the psychosis incident cohort outcome study (PICOS). JPsychiatr Res 2013, 47:438-444.
61. Tsuang M.T., Van Os J., Tandon R., Barch D.M., Bustillo J., Gaebel W., et al. Attenuated psychosis syndrome in DSM-5. Schizophr Res 2013, 150:31-35.
62. Valmaggia L.R., Stahl D., Yung A.R., Nelson B., Fusar-Poli P., Mcgorry P.D., et al. Negative psychotic symptoms and impaired role functioning predict transition outcomes in the at-risk mental state: a latent class cluster analysis study. Psychol Med 2013, 43:2311-2325.
63. Velthorst E., Nelson B., Wiltink S., De Haan L., Wood S.J., Lin A., et al. Transition to first episode psychosis in ultra high risk populations: does baseline functioning hold the key?. Schizophr Res 2013, 143:132-137.
64. Walder D.J., Holtzman C.W., Addington J., Cadenhead K., Tsuang M., Cornblatt B., et al. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophr Res 2013, 144:43-50.
65. Yung A.R., Nelson B., Thompson A., Wood S.J. The psychosis threshold in ultra high risk (prodromal) research: is it valid?. Schizophr Res 2010, 1-6.
66. Yung A.R., Woods S.W., Ruhrmann S., Addington J., Schultze-Lutter F., Cornblatt B.A., et al. Whither the attenuated psychosis syndrome?. Schizophr Bull 2012, 38:1130-1134.
67. Yung A.R., Yuen H.P., Mcgorry P.D., Phillips L.J., Kelly D., Dell'olio M., et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 2005, 39:964-971.
68. Ziermans T., De Wit S., Schothorst P., Sprong M., Van Engeland H., Kahn R., et al. Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up. PLoS One 2014, 9:e93994.